Pharmacokinetic and Pharmacodynamic Profiles of Rapid- and Slow-Acting Antimalarial Drugs
Author:
Publisher
IntechOpen
Link
http://www.intechopen.com/download/pdf/65516
Reference67 articles.
1. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. The New England Journal of Medicine. 2009;361:455-467. DOI: 10.1056/NEJMoa0808859
2. Mathews ES, Odom John AR. Tackling resistance: Emerging antimalarials and new parasite targets in the era of elimination. F1000Research. 2018;7:pii: F1000. DOI: 10.12688/f1000research.14874.1
3. Leang R, Taylor WR, Bouth DM, Song L, Tarning J, Char MC, et al. Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: Dihydroartemisinin-piperaquine open-label multicenter clinical assessment. Antimicrobial Agents and Chemotherapy. 2015;59:4719-4726. DOI: 10.1128/AAC.00835-15
4. Tyagi RK, Gleeson PJ, Arnold L, Tahar R, Prieur E, Decosterd L, et al. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure. BMC Medicine. 2018;16:181. DOI: 10.1186/s12916-018-1156-x
5. Dondorp AM, Fairhurst RM, Slutsker L, Macarthur JR, Breman JG, Guerin PJ, et al. The threat of artemisinin-resistant malaria. The New England Journal of Medicine. 2011;365:1073-1075. DOI: 10.1056/NEJMp1108322
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancing liposome technology for innovative strategies against malaria;Saudi Pharmaceutical Journal;2024-06
2. Investigation of bioorganometallic artemisinins as antiplasmodials;Journal of Organometallic Chemistry;2023-04
3. Imatinib augments standard malaria combination therapy without added toxicity;Journal of Experimental Medicine;2021-08-26
4. Pharmacotherapy for artemisinin-resistant malaria;Expert Opinion on Pharmacotherapy;2021-07-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3